Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...

What are lawmakers doing about this during the 2026 legislative session?

Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

The global Kaposi’s Sarcoma market is expanding due to the HIV/AIDS prevalence, improved oncology infrastructure, and advancements in targeted and immunotherapeutic drugs. Kaposi’s Sarcoma, a tumor ...

New pilot partnership links at-home HIV screening with clinical prevention and treatment services across Ontario. TORONTO, ON ...

For most of its history, the US military has refused to recruit HIV-positive soldiers. The Trump administration appears to be ...

New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...

KUALA LUMPUR: An average of 3,169 new HIV cases were recorded annually between 2018 to 2025, the Dewan Rakyat was told. The ...

Renewing and sustaining syringe exchange programs is essential to protecting public health, saving lives and maintaining the progress we've made.

PLANO, Texas, Jan. 22, 2026 /PRNewswire/ -- Q Care Plus, a telehealth provider known for its leadership in providing HIV ...

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...